FDA Inspection
Shandong Luxi Pharmaceutical Co., Ltd.Shandong Luxi Pharmaceutical Co., Ltd. – FDA Inspection, Jul 24, 2019
Record Details
This FDA Inspection record concerns Shandong Luxi Pharmaceutical Co., Ltd., with an inspection on July 24, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · de895a47-d953-4bb9-a782-5dbe88d30880
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099165
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Luxi Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Shandong Luxi Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.